We’re delighted to have helped our client Kaydiar Limited, an innovative medical device company specialising in offloading technologies, in securing a significant investment of £1.2m for their DiaSole and ZeroSole medical insoles, in addition to supporting their IUK backed R&D project for custom devices.
The investors involved in the private equity investment includes the University of Wales Trinity Saint Davids, DBW’s Tech Venture Fund, and the Women Angels of Wales investor syndicate.
Corporate and Commercial partner Siôn Tudur led the deal, supported by Solicitor Hinna Kerai.
Siôn said:
“We have worked with Kaydiar for a number of years and during this time, we’ve witnessed David and Heather’s commitment to their products and the impact they have had on improving lives. We believe in David and Heather and look forward to continuing to support them on their journey.”
Heather Smart, Co-founder of Kaydiar Limited also commented on the investments:
“As a start-up, we are very grateful to Sion and the Hugh James team for all of the support and guidance they have provided us over the years, and helping us to complete our recent investment raise. This is an exciting and pivotal point for Kaydiar, as landing this investment will accelerate the launch of ZeroSole across over-the-counter foot-care and podiatry channels, whilst also spring-boarding the development of an exciting new technology for the custom device market.”
Kaydiar specialises in pressure-relieving orthotic devices for pressure-induced foot conditions, including diabetic ulcer prevention. Their user-friendly products are not only sought after for their convenience, but they also include innovative features and functions that enhance customer use and patient care.
